Search

everythinglearnresearchcommunity

for

Search:↓

PP405 is a new hair loss treatment facing mixed reactions due to initial hype and insufficient data. Some are hopeful, but many doubt its effectiveness compared to minoxidil and finasteride.

A user reversed severe hair loss with dieting, lifestyle changes, and topical minoxidil, highlighting reduced inflammation and body fat. The conversation debates finasteride's effectiveness and the impact of diet and lifestyle on hair health.

A 19-year-old using finasteride for hair loss seeks advice on additional treatments. Suggestions include microneedling, minoxidil, and ketoconazole shampoo, with concerns about side effects discussed.

Concerns about the long-term effects of dutasteride and finasteride on fertility, with discussions on cycling these medications to mitigate risks. The conversation highlights skepticism about study methodologies and the importance of weighing treatment risks against potential fertility issues.

The user is considering a hair transplant at 25 after experiencing hair loss despite using finasteride, minoxidil, and recently starting dutasteride. They are advised to continue DHT blockers post-transplant to prevent further hair loss and are considered an ideal candidate for a transplant.

Oral minoxidil can cause side effects like shortness of breath and constipation, which may be reduced by taking it in the morning. Some users experience no side effects, while others switch to topical treatments or adjust their dosage and timing to manage symptoms.

The user shared progress after four months of using a topical treatment with 0.3% finasteride and 6% minoxidil from Hims, noting positive results and considering switching to oral medication for convenience. Other users discussed the effectiveness of minoxidil and finasteride, emphasizing that first-time users often see the best results, and shared personal experiences with hair regrowth and maintenance.

The user started oral minoxidil in February 2025 and noticed hair improvement, but paused due to pregnancy. They experienced minimal shedding and some facial hair growth as a side effect.

A 20-year-old is considering starting dutasteride or finasteride for hair loss, with concerns about potential side effects and development. Users shared experiences with both treatments, noting that finasteride is often the first step, while dutasteride may be more effective for some, and emphasized consulting a healthcare provider.

A user stopped finasteride after 15 years due to severe side effects, which improved after quitting. They maintained most of their hair and are considering alternatives like topical treatments or RU58841.

Dutasteride and finasteride for hair loss, with dissatisfaction expressed about dutasteride and consideration of switching back to finasteride. Users share varied experiences, noting individual responses to treatments differ.

A user successfully regrew hair over 12 months using topical minoxidil, topical finasteride, microneedling, and supplements, with no side effects. They credit their success to consistency and a comprehensive routine.

The user experienced significant hair regrowth using oral minoxidil and dutasteride over several months. Many commenters praised the progress and suggested additional treatments like microneedling for further improvement.

A 38-year-old has maintained hair with finasteride for 17 years, recently adding oral minoxidil for improvement. Users discuss experiences with finasteride, dutasteride, and minoxidil, noting effectiveness, side effects, and costs.

Access to minoxidil and finasteride in prison is unlikely unless prescribed for medical conditions like hypertension or benign prostatic hyperplasia. Cosmetic treatments are generally not provided in prison.

A woman experienced significant hair regrowth after six months of using dutasteride and minoxidil, despite initial hair loss due to androgenetic alopecia. She reported minimal side effects and highlighted the effectiveness of these treatments for women, despite doctors' hesitancy to prescribe them.

A 19-year-old has been using oral finasteride and minoxidil for a year without noticeable results. Suggestions include adding derma-stamping, increasing ketoconazole shampoo use, and considering vitamin D testing, while acknowledging that response times vary.

PP405 is a potential hair loss treatment, but its safety and effectiveness are uncertain. Users advise caution and suggest waiting for more data before purchasing unverified versions.

A 23-year-old shared their successful hair regrowth experience using 2.5mg oral Minoxidil and 1mg Finasteride, noting significant improvement between months 4 to 7 with minimal side effects like bloating. They plan to continue treatment until it stops working or they turn 30, and they are open to embracing baldness in the future.

Switching from finasteride to dutasteride caused significant shedding but minimal side effects. The user plans to continue dutasteride for 12 months despite concerns about hair density.

Low-dose oral minoxidil is a safe and effective hair loss treatment with fewer side effects than previously feared. Users often prefer it over topical minoxidil for better results, though some experience side effects like increased body hair and cardiovascular issues.

A young person is distressed about rapid hair loss despite using finasteride and recently starting oral minoxidil. Many suggest continuing treatment, considering dutasteride, and seeking therapy for mental health support.

Dutasteride significantly reduces DHT levels, potentially more effectively than finasteride, and is used to treat hair loss. Some users report side effects like reduced libido and mood changes, while others experience hair regrowth and increased testosterone.

People are discussing obtaining and testing PP405 for hair loss treatment, with concerns about its purity and effectiveness. Some are considering delaying hair transplants, while others suggest using existing treatments like finasteride and minoxidil.

PP405 shows promise in hair regrowth, with 31% of participants experiencing over 20% increase in hair density after 8 weeks. Phase 3 trials are expected in 2026, with potential market availability by 2029-2031.

A physician experienced hair thickening and new growth using microneedling and minoxidil, but stopped using topical finasteride due to side effects like reduced libido and erectile dysfunction. The physician plans to continue with microneedling and minoxidil, considering finasteride nonessential for cosmetic purposes.

The user has been using oral and topical minoxidil, finasteride, dermastamping, and multivitamins for hair loss, with plans to consider a hair transplant in the future. They are seeing gradual improvement and are content with the progress, preferring to stick with their current regimen rather than switching to other treatments like dutasteride.

Minoxidil's effectiveness is limited by the need for sulfation and proper transport to hair follicles, with tretinoin potentially enhancing its effects by promoting enzyme activity and keratinocyte differentiation. Tretinoin may improve minoxidil's response by boosting the expression of necessary enzymes and transporters.

PP405 is a potential hair loss treatment that may work by blocking signals that cause hair cells to stop growing, requiring daily application for effectiveness. It could serve as an alternative to minoxidil and finasteride, but it is not yet available on the market and may take several years to be released.

The user shared their hair loss treatment progress using topical products like exosomes, fluridil, Kx826, and topical dutasteride, avoiding oral finasteride and dutasteride due to side effects. They found exosomes from Creative Biolabs most effective and also used topical probiotics, noting improvements without significant side effects.